Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer

Lee, Nancy Y.; Morris, Luc G. T.; Diehn, Maximilian

doi:10.1001/jamaoncol.2024.1821

JAMA Oncol

2024

DOI: 10.1001/jamaoncol.2024.1821

|View full text |Cite

Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer

Nancy Y. Lee,

Luc G. T. Morris,

Maximilian Diehn

Abstract: This Viewpoint evaluates the use of tumor tissue–modified human papillomavirus (HPV) DNA in identifying minimal residual disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies

Liu,

Huang,

Ailles

et al. 2024

Annals of Oncology

View full text Add to dashboard Cite

Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies

Liu,

Huang,

Ailles

et al. 2024

Annals of Oncology

View full text Add to dashboard Cite

Minimal residual disease as a target for liquid biopsy in patients with solid tumours

Pantel,

Alix-Panabières

2024

Nat Rev Clin Oncol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer

Abstract: This Viewpoint evaluates the use of tumor tissue–modified human papillomavirus (HPV) DNA in identifying minimal residual disease.

Cited by 2 publications

References 7 publications

Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies

Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies

Minimal residual disease as a target for liquid biopsy in patients with solid tumours

Contact Info

Product

Resources

About